Javascript must be enabled to continue!
Primary PCI in Elderly STEMI Patients: Risk Assessment and Management
View through CrossRef
Objective: To evaluate the impact of frailty on clinical and procedural outcomes in elderly STEMI patients undergoing primary percutaneous coronary intervention (PCI) at Hayatabad Medical Complex, Peshawar. Methodology: A retrospective study was conducted from April 2023 to March 2024, including 300 patients aged ≥65 years divided equally into frail and non-frail groups (n=150 each). Data were collected on demographic characteristics, procedural outcomes, and complications. Statistical analysis included chi-square tests for categorical variables and t-tests for continuous variables, with a significance level of p<0.05. Results: The mean Killip class was significantly higher in frail patients (2.5 ± 0.8) compared to non-frail patients (1.8 ± 0.5; p<0.05). Symptom onset-to-treatment time was longer among frail patients (7.4 ± 2.1 hours vs. 5.8 ± 1.9 hours; p<0.05). TIMI grade 3 flow was achieved in 82% of non-frail patients compared to 65% in frail patients (p<0.05). Major adverse cardiac events (MACE) occurred in 42% of frail patients versus 18% of non-frail patients (p<0.05). ST-segment resolution was achieved in 78% of non-frail patients compared to 54% in frail patients (p<0.05). Conclusion: Frailty significantly impacts clinical and procedural outcomes in elderly STEMI patients, highlighting the need for tailored approaches to improve treatment and post-PCI care. Future studies should validate these findings in broader populations and explore advanced strategies to address frailty.
Title: Primary PCI in Elderly STEMI Patients: Risk Assessment and Management
Description:
Objective: To evaluate the impact of frailty on clinical and procedural outcomes in elderly STEMI patients undergoing primary percutaneous coronary intervention (PCI) at Hayatabad Medical Complex, Peshawar.
Methodology: A retrospective study was conducted from April 2023 to March 2024, including 300 patients aged ≥65 years divided equally into frail and non-frail groups (n=150 each).
Data were collected on demographic characteristics, procedural outcomes, and complications.
Statistical analysis included chi-square tests for categorical variables and t-tests for continuous variables, with a significance level of p<0.
05.
Results: The mean Killip class was significantly higher in frail patients (2.
5 ± 0.
8) compared to non-frail patients (1.
8 ± 0.
5; p<0.
05).
Symptom onset-to-treatment time was longer among frail patients (7.
4 ± 2.
1 hours vs.
5.
8 ± 1.
9 hours; p<0.
05).
TIMI grade 3 flow was achieved in 82% of non-frail patients compared to 65% in frail patients (p<0.
05).
Major adverse cardiac events (MACE) occurred in 42% of frail patients versus 18% of non-frail patients (p<0.
05).
ST-segment resolution was achieved in 78% of non-frail patients compared to 54% in frail patients (p<0.
05).
Conclusion: Frailty significantly impacts clinical and procedural outcomes in elderly STEMI patients, highlighting the need for tailored approaches to improve treatment and post-PCI care.
Future studies should validate these findings in broader populations and explore advanced strategies to address frailty.
Related Results
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Objectives
This study was to investigate the safety and efficacy of thrombolysis followed by early PCI via transradial artery approach in patients with ST-segment...
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Background: Recently, many hospitals in Yemen have been started using Percutaneous Coronary Intervention (PCI) procedure for treatment coronary artery disease (CAD), including Dr. ...
Early percutaneous coronary intervention after thrombolysis in STEMI: the early-PCI pilot feasibility study
Early percutaneous coronary intervention after thrombolysis in STEMI: the early-PCI pilot feasibility study
Introduction
Primary percutaneous coronary intervention (PCI) is the preferred treatment for patients with STEMI now. But few patients can receive it within 90 mi...
GW24-e3094 Timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease
GW24-e3094 Timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease
Objectives
Over 50% of ST-segment elevation myocardial infarction (STEMI) patients have multivessel disease, which is known to be associated with worse prognosis....
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
Objectives
The Novel approaches for preventing or limiting events (NAPLIES) and The Atorvastatin for Reduction of Myocardial Damage during Angioplasty (ARMYDA) st...
Managing bifurcations: are two stents better than one?
Managing bifurcations: are two stents better than one?
Abstract
Introduction
Bifurcation percutaneous coronary intervention (PCI) is associated with a higher degree of complexity when...
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Objective
Percutaneous Coronary Intervention (PCI) is a technique of cardiac intervention treatment in revascularisation of coronary vessel. The use of PCI in pat...
Pharmaco-invasive PCI for STEMI-What are the outcomes?
Pharmaco-invasive PCI for STEMI-What are the outcomes?
As pharmaco-invasive Percutaneous Coronary Intervention (PCI) remains an important treatment modality for patients with ST-Elevation Myocardial Infarction (STEMI), this review aims...

